The British inspectorate MHRA has recently published an interpretation that goes into detail on the use of health based exposure limits and explains the cases where EMA’s new concept can be applied. One essential element of that concept is EMA’s Q&A Paper describing when a product should be classified as highly active.
http://www.gmp-compliance.org/gmp-news/mhras-interpretation-of-cross-contamination-pdes